Shanghai Kaibao Pharmaceutical (300039.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100000JZ3
Shanghai Kaibao Pharmaceutical financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.47 bn CNY | 1.15 bn CNY |
| Gross profit | 1.20 bn CNY | 930.62 m CNY |
| Operating income | 438.25 m CNY | 272.44 m CNY |
| EBIT | 434.33 m CNY | 322.15 m CNY |
| Net income | 375.58 m CNY | 278.58 m CNY |
| Diluted EPS – continuing operations | 0.36 CNY | 0.27 CNY |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai Kaibao Pharmaceutical
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, including Thiopronine for injection and Thiopronine enteric-coated tablets. In addition, the company provides Astragalus and Ginseng Capsules for the treatment of cardiovascular and cerebrovascular diseases. Further, it offers diclofenac sodium enteric-coated tablets; artificial bezoar metronidazole capsules; Mai'an granules; Loquat cough granules that clears the lungs, relieves cough, and reduces phlegm; compound danshen tablets; Tongmai granules to promote blood circulation and unblocks meridians; pediatric pharyngeal granules; stroke rejuvenation pills; and Xiao Chai Hu granules which relieves exterior syndromes, clears heat, soothes the liver, and harmonizes the stomach. Further, the company provides Alopecia areata; Bear bile drops that clears heat, calms the liver, and improves eyesight, as well as used for infantile convulsions and sore throat; and Shanhaidan capsules. Shanghai Kaibao Pharmaceutical CO.,Ltd was founded in 2000 and is based in Shanghai, China.
More stocks
- WAM Capital Ltd (WAM.AX)
- Pason Systems Inc. (PSI.TO)
- Global Top E Commerce Co Ltd (002640.SZ)
- Poly Plastic Masterbatch Suzhou Co (300905.SZ)
- HPGC Renmintongtai Pharmaceutical Corp (600829.SS)
- MTT Shipping and Logistics Berhad (5352.KL)
- Hangzhou Haoyue Personal Care Co Ltd (605009.SS)
- Yext, Inc. (YEXT)
- Shenzhen LeoKing Environmental Group Co. Ltd. A (301305.SZ)
- Criteo S.A. (CRTO)
- YIFILASER ORD A (SHH) EQSW Exp: (688646.SS)
- DINE S.A.B. de C.V (DINEB.MX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.